May 20th 2024
Both the World Health Organization and FDA have now recommended this particular set of viruses be left off influenza vaccines for 2024-2025 respiratory virus season. A new study points to further evidence of their extinction.
Surv.AI Says: Real-World Insights into the Journey for Patients with Pulmonary Arterial Hypertension
May 21, 2024
Register Now!
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
May 21, 2024
Register Now!
Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?
View More
Understanding RSV: What You Need to Know to Prevent and Treat Respiratory Syncytial Virus in Your Patients
View More
Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines
View More
(COPE Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
(CME Credit) Community Practice Connections™: Keeping an Eye on Evolving Management Strategies for nAMD and DME
View More
Medical Crossfire®: Which Patients with Hematologic Malignancies are at Risk for Secondary Immunodeficiency (SID)… and How Can We Leverage Evidence to Improve Their Outcomes?
View More
Addressing Healthcare Inequities™ in Glaucoma Management – Understanding Challenges in Segmented Patient Populations (CME Track)
View More
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
View More
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
View More
6th Annual Advanced Practice Collaborative
View More
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
Let’s Get “Real”: Alpha-1 Antitrypsin Deficiency—Case-Based Perspectives on Managing Associated Emphysema
View More
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Identifying Actionable Biomarkers in NSCLC: Real World Case Discussions on Applications of Testing in the Treatment Planning Process
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Improving Outcomes Across Frontline and R/R SCLC Care in Community Treatment Settings
View More
Addressing Healthcare Inequities: Bridging the Gap in Multiple Sclerosis – A Focus on Clinical and Healthcare Disparities in Black Patients
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
Overcoming Racial Disparities in Multiple Myeloma Outcomes and Clinical Trials: How We are Moving Care Forward Today
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Charting the Path to Precision Diagnosis: Detection and Treatment Approaches for Oncogenic Mutations in NSCLC
View More
Shorter Antibiotic Regimens Recommended for Treatment of Pneumonia
August 1st 2016The IDSA and ATS have updated the Clinical Practice Guidelines for HAP & VAP for the first time since 2005 to recommend that each hospital generate antibiograms and reduce the use of antibiotics in treatment regiments.
Read More
Have Researchers Finally Found the Key to a Universal Influenza Vaccine?
July 28th 2016Investigators at the National Institute of Allergy and Infectious Diseases (NIAID) and the National Human Genome Research Institute (NHGRI) believe they have found the key to developing a universal vaccine for influenza.
Read More
Enterovirus Associated with "Polio-like Syndrome" in Pediatric Patients
July 25th 2016Following an outbreak of acute flaccid myelitis (AFM) identified at Children’s Hospital Colorado in Aurora over three months in 2014, a potential association has been found between enterovirus D68 (EV-D68) infection and AFM in pediatric patients.
Read More
What is an Infectious Disease That Needs Greater Attention Right Now?
July 21st 2016Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response at the Centers for Disease Control and Prevention (CDC) shares which infectious disease he feels needs greater attention.
Read More
Long-term Effects of Reduced Antibiotic Use for RTIs Far Outweigh Potential Short-term Consequences
July 19th 2016The belief that patients may face increased risks of complications following reduced antibiotic use after experiencing self-limiting respiratory tract infections (RTIs) may not be well-founded.
Read More
Knowledge of Latest Diagnostic Tests for TB Lacking in Low-Prevalence Settings
June 30th 2016As the incidence of tuberculosis (TB) continues to decline in low-prevalence settings such as the United States, there is some concern within the infectious disease/public health field that clinicians may not be aware of the latest diagnostic technologies available to screen for the disease.
Read More
CDC Advises Against Use of Nasal Spray Flu Vaccine for the 2016-2017 Flu Season
June 23rd 2016The Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has voted against the use of the live attenuated influenza vaccine (LAIV), or “nasal spray,” for the 2016-2017 flu season.
Read More
Treatment for MERS May Be Discovered Through Alpacas
June 10th 2016An international team of researchers may have identified a potential animal model for use in the laboratory as part of efforts to better understand the pathogenesis of Middle East respiratory syndrome (MERS) coronavirus and, hopefully, find an effective treatment for it: alpacas.
Read More
CDC Reports: Recent Legionnaires' Disease Outbreaks Could Have Been Prevented
June 9th 2016A new report from the Centers for Disease Control and Prevention (CDC) suggests that many of the reported outbreaks involving Legionella bacteria since 2000 could have been prevented with better testing protocols and infrastructure management.
Read More
Integrity is Basis of Public Health Work
June 8th 2016Public health demands integrity, said Margaret Hamburg, MD, former commissioner of the US Food and Drug Administration (FDA), at the Centers for Disease Control and Prevention’s 65th Annual Epidemic Intelligence Service (EIS) Conference in Atlanta, Georgia.
Read More
Influenza Vaccine During Pregnancy May Protect Newborn Infants
May 31st 2016The number of expecting mothers who opt for annual vaccination for influenza during pregnancy remains relatively low; however, the results of a new study suggest this may be changing—and that there are obvious benefits for immunization for newborns.
Read More
Global Influenza Surveillance Program Shows Promising Results
May 27th 2016A program designed to improve the quality of influenza surveillance capabilities in 39 countries from around the globe through partnership with the Centers for Disease Control and Prevention (CDC) seems to have resulted in remarkable progress on all six of the assessed metrics, and even led to improvements in the surveillance of other pathogens, according to the results of a recent study.
Read More
Challenging the Gold Standard for Evaluating Influenza Vaccines
May 26th 2016The level of hemagglutination inhibition (HAI) used as the traditional gold standard for evaluating influenza vaccines in the United States and European Union may not actually be the best predictor of protection from influenza virus-induced disease.
Read More
Asymptomatic Influenza Infection Rates Deserve More Attention
May 20th 2016The consequences of not understanding the actual rate of asymptomatic influenza infection can be grave, as influenza virus infection of the respiratory tract has been shown to result in severe disease and complications, including pneumonia, shock, renal failure, encephalopathy, and multiorgan dysfunction, which can be lethal.
Read More
The CDC Epidemic Intelligence Service Takes Aim at Tuberculosis at Recent Conference
May 13th 2016Officers of the CDC’s Epidemic Intelligence Service (EIS) presented recent research on tuberculosis (TB) on May 3 in a session at the 65th Annual Epidemic Intelligence Service Conference in Atlanta, Georgia. A summary of the presentations is included in this article.
Read More
Recent Influenza Research by the CDC Epidemic Intelligence Service
May 11th 2016Public health leaders have serious concerns about influenza, according to Dan Jernigan, MD, MPH, director of the Centers for Disease Control and Prevention (CDC) Influenza Division during a session on influenza on May 2nd during the 65th Annual Epidemic Intelligence Service (EIS) Conference in Atlanta, Georgia.
Read More
Research on Universal Vaccine for Influenza Uncovers More Than Just Financial Limitations
May 2nd 2016A recent review article on the status of influenza vaccines, their short-comings, and ways to improve them suggests the potential for significant improvements in the performance of future influenza vaccines.
Read More
Study Calls for Alternatives to Egg-Based Manufacturing of Influenza Vaccines
April 28th 2016Because certain viral sub-types are associated with higher rates of morbidity and mortality than others, efforts to improve the effectiveness of influenza vaccines remain an important focus of future research.
Read More
Is There a Legionnaire's Epidemic Brewing in the United States?
April 25th 2016The impact of the water crisis in Flint, Michigan now includes an infectious disease component—namely, an outbreak of Legionnaire’s disease—and it has sparked a debate among health officials and infectious disease experts.
Read More